Literature DB >> 23278432

Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes.

J B Dixon1, K-Y Hur, W-J Lee, M-J Kim, K Chong, S-C Chen, N-E Straznicky, P Zimmet.   

Abstract

AIM: To assess factors influencing glycaemic control following gastric bypass surgery in patients with Type 2 diabetes and BMI< 30 kg/m(2) .
METHODS: Prospective longitudinal study of 103 patients with inadequate glycaemic control who underwent gastric bypass surgery at Soonchunhyang University, Seoul, Korea (n = 66) and Min-Sheng General Hospital, Taipei, Taiwan (n = 37). Procedures were performed August 2009 to January 2011. Key outcome measures were excellent glycaemic control of Type 2 diabetes defined as HbA1c < 42 mmol/mol (≤6%); inadequate response defined as HbA1c > 53 mmol/mol (> 7%). Analysis was conducted using binary logistic regression, and cut-points obtained from receiver operator characteristics.
RESULTS: Excellent glycaemic control was achieved in 31 (30%) at 1 year. Diabetes duration of < 7 years and BMI > 27 kg/m(2) provided independent predictors and useful cut-points. Likelihood of excellent glycaemic control for an individual could be estimated using loge (Odds) = -6.7 + (0.26 × BMI) + (-1.2 × diabetes duration). Baseline BMI of < 27 kg/m(2) and baseline C-peptide of < 2.0ng/ml, best predicted a poor glycaemic response. In those with favourable baseline characteristics percentage weight loss (%WL) had a dominant influence on glycaemic outcomes. Baseline C-peptide (> 2.4 ng/ml) and subsequent percentage weight loss (> 16%) were associated with excellent glycaemic control. Higher BMI was associated with greater percentage weight loss.
CONCLUSION: In patients with Type 2 diabetes and BMI < 30 kg/m(2) , glycaemic response to gastric bypass is predicted by higher baseline BMI, shorter disease duration and higher fasting C-peptide. Post-surgery weight loss has a dominant effect. Baseline BMI and weight loss have a major influence on outcomes.
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23278432     DOI: 10.1111/dme.12107

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  34 in total

1.  Letter to "Predictive Factors of Type 2 Diabetes Mellitus Remission Following Bariatric Surgery: a Meta-analysis".

Authors:  Yue-Lin Fang; Abdullah M Almulaifi; Wei-Jei Lee
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

2.  Preoperative Predictive Factors of Successful Weight Loss and Glycaemic Control 1 Year After Gastric Bypass for Morbid Obesity.

Authors:  Silvia Palmisano; Marta Silvestri; Michela Giuricin; Edoardo Baldini; Simone Albertario; Patrizio Capelli; Bernardo Marzano; Giovanni Fanti; Aron Zompicchiatti; Paolo Millo; Massimiliano Fabozzi; Riccardo Brachet Contul; Riccardo Brachet Contul; Elisa Ponte; Rosaldo Allieta; Nicolò de Manzini
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

3.  Predictors of long-term diabetes remission after metabolic surgery.

Authors:  Ming Hsien Lee; Wei-Jei Lee; Keong Chong; Jung-Chien Chen; Kong-Han Ser; Yi-Chih Lee; Shu-Chun Chen
Journal:  J Gastrointest Surg       Date:  2015-04-04       Impact factor: 3.452

4.  [Efficacy of two bariatric surgeries in type 2 diabetic patients with a body mass index of 25-27.5].

Authors:  Hao Yu; Xiao-Jiang Dai; Hong-Bing Zhang; Yong-Tao Huang; Dong-Zhi Ran; Yuan Yang; Song-Hua Zeng; Zhi-Gao Song; Liang-Ping Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

Review 5.  Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence.

Authors:  Wei-Jei Lee; Yu-Hung Lin
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

6.  The Effect of Bariatric Surgery on Asian Patients with Type 2 Diabetes Mellitus and Body Mass Index < 30 kg/m2: a Systematic Review and Meta-analysis.

Authors:  Guangnian Ji; Pengzhou Li; Weizheng Li; Xulong Sun; Zhaomei Yu; Rao Li; Liyong Zhu; Shaihong Zhu
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

7.  Prediction of Long-Term Diabetes Remission After Metabolic Surgery in Obese East Asian Patients: a Comparison Between ABCD and IMS Scores.

Authors:  Masayuki Ohta; Yosuke Seki; Tetsuji Ohyama; Rixing Bai; Sang Hyun Kim; Takashi Oshiro; Tao Jiang; Akira Sasaki; Takeshi Naitoh; Tsuyoshi Yamaguchi; Susumu Inamine; Yasuhiro Miyazaki; Soo Min Ahn; Yoonseok Heo; Hui Liang; Seung Ho Choi; Wah Yang; Qiyuan Yao; Kentaro Inoue; Hiroshi Yamamoto; Hyuk-Joon Lee; Young Suk Park; Tae Kyung Ha; Seung-Wan Ryu; Cunchuan Wang; Sungsoo Park; Kazunori Kasama
Journal:  Obes Surg       Date:  2021-01-07       Impact factor: 4.129

8.  Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect.

Authors:  Wei-Jei Lee; Keong Chong; Yu-Hung Lin; Jih-Hua Wei; Shu-Chun Chen
Journal:  Obes Surg       Date:  2014-09       Impact factor: 4.129

9.  Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Type 2 Diabetes Mellitus.

Authors:  Yosuke Seki; Kazunori Kasama; Akiko Umezawa; Yoshimochi Kurokawa
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

10.  Diagnosis of diabetes remission after bariatic surgery may be jeopardized by remission criteria and previous hypoglycemic treatment.

Authors:  Ana Ramos-Levi; Andres Sanchez-Pernaute; Pilar Matia; Lucio Cabrerizo; Ana Barabash; Carmen Hernandez; Alfonso Calle-Pascual; Antonio Torres; Miguel Rubio
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.